Business - Briefly   

Venus gets nod for Cephalosporin FDC

MUMBAI: Venus Remedies has received approval from the Drug Controller General of India (DCGI) for launching fixed dose combination (FDC) drug of Cephalosporin. The company will launch the new FDC under strategic marketing tie-ups with leading pharma companies. It had already filed patent applications for the product, the company informed the Bombay Stock Exchange.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Drug cos. to limit margin on generics
Rolta, Thales form joint venture
Sensex up 29 points
HM rolls out Mitsubishi Montero
CCS Infotech to form JV in South Africa
Blue Dart convenes EGM to de-list shares
We have no fight with Tatas, says B. K. Birla
`Pesticide controversy not to impact FDI'
Rising fuel price dents business confidence
Rupee ends 14 paise higher against $
Bullion rates
Exchange rates
Panel on insurance brokers norms
ICICI Bank offloads entire stake in IDFC
Murthy to join TiE Board of Trustees
Indo-Russian hi-tech centre opens in Siberia
Suguna poultry's expansion plans
LVB launches new deposit, loan products
Sundaram Infotech launches ERP academy
KSB Pumps introduces new submersible pumpset
Juki Expo 2006
Venus gets nod for Cephalosporin FDC
Renault-Nissan Institute ties up with Omnex
New COO for Sify
Nippon Paint launched
Virtusa's new HR director
HTMT completes stake sale in Hutchison Essar
Matchmaking for PR consultancies
IPv6 Forum signs MoU with Chinese council
IACC award for Cisco Systems
Mann-Hummel opens subsidiary in Tumkur
Freescale expands presence in Bangalore
Syndicate Bank's new deposit scheme

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu